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Volume 59, Number 6S Abstracts 9SMethods: Digital computed tomography angiography
was analyzed in 520 consecutive patients treated by open
or fenestrated endovascular repair for complex abdominal
aortic aneurysms (AAAs, 2000-2012). RA/ARA anatomy
was assessed using diameter, length, angles, and kidney
perfusion based on analysis of volumetric kidney paren-
chyma (VKP, Fig). Endovascular suitability was deter-
mined by RA diameter $4 mm, length to RA bifurcation
$13 mm, and preservation of >60% of one or >75% of
both kidneys by VKP analysis.
Results: There were 222 juxtarenal (43%), 241 supra-
renal (46%), and 57 type IV thoracoabdominal aortic aneu-
rysms (11%). A total of 1009 RAs and 176 ARAs were
analyzed. Endovascular incorporation was possible in 884
RAs (88%) and in 30 ARAs (17%). Using the proposed
criteria, 97 patients (19%) had one or more factors
rendering RA incorporation unsuitable, including early
bifurcation in 45 (9%), small diameter in 29 (6%), or
inability to preserve kidney parenchyma in 28 (5%). A total
of 170 patients (33%) had other anatomic issues that would
increase technical difﬁculty to RA incorporation, including
excessive downward angulation in 125 (24%), high-grade
stenosis in 51 (10%), or prior renal stents in 11 (2%).
Conclusions: Independent of the endovascular tech-
nique selected to treat a complex AAA, one of ﬁve patients
(19%) is not a candidate and one-third have anatomic chal-
lenges (33%) for RA incorporation. Patients with unsuit-
able RA anatomy may need open repair to maximize
renal artery patency and preserve renal function.
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Objectives: The natural history of renal artery aneu-
rysms (RAAs) is not well documented. We present an 18-
year experience of patients with untreated RAAs.
Methods: A retrospective review was performed for
patients with RAAs (1995 to 2013). Patients who wereobserved and had at least two studies (computed tomogra-
phy/magnetic resonance imaging) were included. Signiﬁ-
cant aneurysm growth was deﬁned as >3 mm.
Results: Seventy-one aneurysms were analyzed. Mean
age on presentation was 69.76 12.3 years, and 63.4% were
female. Mean initial diameter was 1.29 6 0.54 cm (range,
0.5-3.7 cm). There was a mean of 2.8 studies per patient;
mean follow-up was 33.2 6 32.4 months. Detailed clinical
information was available in 48 patients. The most com-
mon comorbidities were hypertension (79%), hyperlipid-
emia (50%), and a smoking history (48%); 16.7% had
renal insufﬁciency, and 17% had other arterial aneurysms.
Among the cohort, the mean annual growth rate was
0.077 6 0.023 cm. Only four of 71 (5.6%) grew >3 mm
during the study period. By survival analysis, gender was
not a risk factor for growth (P ¼ .08). Only smoking was
found to be a signiﬁcant risk factor for growth; current
smokers were signiﬁcantly more likely to have growth >3
mm than former smokers or nonsmokers (30% incidence
of growth among current smokers vs 8.3% and 0% respec-
tively; P < .02). Survival analysis demonstrated that larger
aneurysms (>1.5 cm at presentation) had signiﬁcantly less
freedom from growth than smaller aneurysms (P ¼ .009).
There were no known ruptures, and no patient required
RAA intervention.
Conclusions: Small RAAs exhibit a slow annual
growth rate. Active smokers and those with a >1.5 cm
diameter on presentation may have more rapid growth.
In particular, current smokers have a high incidence
(30%) of clinically meaningful aneurysm growth. Neverthe-
less, this relatively large and longer-term natural history
study of observed RAAs supports observation for most
small RAAs in patients who do not have a clear indication
for surgical repair.
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Objectives: A substantial number of patients with
threatened arteriovenous (AV) access are found to have ste-
noses at the costoclavicular junction (CCJ), which
frequently are resistant to angioplasty and stenting. We hy-
pothesized that stenoses in this location will not resolve un-
less bony decompression is performed to relieve the
extrinsic venous compression.
Methods: We reviewed a prospectively maintained
database to identify all patients with threatened AV access
operated on for stenoses at the CCJ.
Results: Between July 2012 in December 2013, 24
patients with threatened access were operated on for CCJ
stenoses at our institution. Fifteen had highly dysfunctional
AV ﬁstulas otherwise felt to need ligation, 10 had signiﬁ-
cant arm and or head swelling, and three required access
but had no contralateral options. In six patients, the
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these had stents in place. Decompression was performed
via claviculectomy in three patients, two of whom under-
went reconstruction, and one was stented. The other 21
underwent ﬁrst rib resection, 20 via an infraclavicular expo-
sure; 11 patients underwent post decompression stenting.
The 30-day morbidity was minimal: there was one signiﬁ-
cant hematoma and one hemothorax in a patient who un-
derwent on-table thrombolysis and no deaths. At follow-up
up to 1 year (median, 5 months), 1 patient died of unre-
lated causes, and one patient undergoing central recon-
struction with prosthetic required excision for infection.
Assisted primary patency of the ﬁstula was 88%, and of
the central bypass, 78%. The index arm continued to be
used for access in 93% of patients, and overall survival
was 91%.
Conclusions: In this group of patients whose access
was judged otherwise nonsalvageable, excellent long-term
ﬁstula and ipsilateral arm use can be achieved with aggres-
sive decompression of the bony CCJ. Stents placed after
such decompression seem to have good intermediate-
term patency in this high-ﬂow situation.
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Objectives: Although rare, endovascular aneurysm
repair EVAR explantation (EX) may be more complex
than an initial open repair (OR). We compared EX with
primary OR aneurysm repair in a case-controlled manner.
Methods: From 1998 to 2013, 46 EX (only infrarenal
EVAR) and 1624 OR were treated. EX and OR groups
were matched (3:1) for age, gender, and Society for
Vascular Surgery/American Association for Vascular Sur-
gery comorbidity score.
Results: The 46 cases (EX) and 138 controls (OR)
included 164 men (41 EX, 123 OR; mean age, 71 years)
and 20 women (ﬁve EX, 15 OR; mean age, 73 years).
Mean SVS scores were 4.87 for EX and 4.88 for OR. EX
indications were infection in 24 (52%), type I endoleak in
8 (17%), complex endoleak in 5 (11 %), and type II endo-
leak in 4 (9%). Aortic clamp was suprarenal in 38 EX (83%)
and in 43 OR (31%). Complications were higher for EX
compared with OR (early: 61% EX vs 20% OR [P <
.001]; late: 20% EX vs 6% OR [P ¼ .008]). Mean LOS
was 17 (EX), 9.6 (OR) days (P < .001). Mean follow-up
was 1.8 years (EX) and 5.1 years (OR). The 30-day overall
mortality was similar: two EX (4%) vs one OR (1%; P ¼
.15). Four EX (9%) and 10 OR (8%) were ruptured; one
of each group died <30 days. Long-term survival was bet-
ter for OR vs EX (non-infected and infected (Fig).
Conclusions: EX, even for noninfected indications, is
associated with increased morbidity and reduced long-term survival compared with matched primary OR. These
data emphasize the need for careful EVAR patient selection
because open reintervention after EVAR is inferior to pri-
mary OR.
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Impact of Renal Artery Angulation on Procedural
Complexity During Fenestrated and Snorkel EVAR
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Objectives: To determine the relationship of renal ar-
tery angulation (RAA) on time to target branch vessel cath-
eterization and procedural efﬁciency during fenestrated
(f-EVAR) and snorkel (sn-EVAR) endovascular aortic
repair (EVAR).
Methods: We reviewed imaging and procedural logs
of 77 patients undergoing complex EVAR (53 sn-EVAR,
24 f-EVAR) from 2010 to 2013. RAA was measured on
preoperative computed tomography angiography, with
positive or negative orientation based on the relative posi-
tion above or below the plane perpendicular to the lateral
aortic wall at the level of each renal ostium. Intraprocedural
time to renal artery catheterization was recorded and
compared with preoperative RAA as well as periprocedural
metrics.
Results: Included were 111 renal artery catheteriza-
tions (72 sn-EVAR, 39 f-EVAR). Mean RAA was
e28 6 21 (range, 37 to e60) for f-EVAR and e30
6 19 (range, 22 to e65) for sn-EVAR (P ¼ .66).
Comparative analysis using median RAA (e30 for
both f-EVAR and sn-EVAR) demonstrated that less down-
ward angulated renals were associated with longer catheter-
ization times for sn-EVAR (18.1 vs 12.3 minutes, P ¼ .04),
